BRPI0806970A2 - Compostos e composições como inibidores de protease de ativação de canal - Google Patents
Compostos e composições como inibidores de protease de ativação de canalInfo
- Publication number
- BRPI0806970A2 BRPI0806970A2 BRPI0806970-0A2A BRPI0806970A BRPI0806970A2 BR PI0806970 A2 BRPI0806970 A2 BR PI0806970A2 BR PI0806970 A BRPI0806970 A BR PI0806970A BR PI0806970 A2 BRPI0806970 A2 BR PI0806970A2
- Authority
- BR
- Brazil
- Prior art keywords
- compositions
- compounds
- protease inhibitors
- channel activate
- activate protease
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88900807P | 2007-02-09 | 2007-02-09 | |
| PCT/US2008/050289 WO2008097673A1 (en) | 2007-02-09 | 2008-01-04 | Compounds and compositions as channel activating protease inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0806970A2 true BRPI0806970A2 (pt) | 2014-04-08 |
Family
ID=39322557
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0806970-0A2A BRPI0806970A2 (pt) | 2007-02-09 | 2008-01-04 | Compostos e composições como inibidores de protease de ativação de canal |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20100239551A1 (pt) |
| EP (1) | EP2117541A1 (pt) |
| JP (1) | JP2010518097A (pt) |
| CN (1) | CN101646437A (pt) |
| AR (1) | AR065266A1 (pt) |
| AU (1) | AU2008214214B2 (pt) |
| BR (1) | BRPI0806970A2 (pt) |
| CA (1) | CA2677485A1 (pt) |
| CL (1) | CL2008000408A1 (pt) |
| EA (1) | EA200901082A1 (pt) |
| MX (1) | MX2009008493A (pt) |
| PE (1) | PE20081753A1 (pt) |
| TW (1) | TW200845982A (pt) |
| WO (1) | WO2008097673A1 (pt) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008519840A (ja) | 2004-11-10 | 2008-06-12 | ジェンザイム・コーポレイション | 糖尿病の処置方法 |
| WO2007134086A2 (en) | 2006-05-09 | 2007-11-22 | Genzyme Corporation | Methods of treating fatty liver disease comprising inhibiting glucosphingolipid synthesis |
| US7951823B2 (en) | 2006-05-23 | 2011-05-31 | Irm Llc | Compounds and compositions as channel activating protease inhibitors |
| KR20090108131A (ko) * | 2007-02-09 | 2009-10-14 | 아이알엠 엘엘씨 | 채널 활성화 프로테아제 억제제로서의 화합물 및 조성물 |
| EP2594562B1 (en) | 2007-05-31 | 2016-07-20 | Genzyme Corporation | 2-acylaminopropanol-type glucosylceramide synthase inhibitors |
| KR101640263B1 (ko) | 2007-10-05 | 2016-07-15 | 젠자임 코포레이션 | 세라마이드 유도체로 다낭성 신장질환을 치료하는 방법 |
| JP2011529500A (ja) | 2008-07-28 | 2011-12-08 | ジェンザイム コーポレーション | 虚脱性糸球体症および他の糸球体疾患の処置のためのグルコシルセラミドシンターゼ阻害 |
| US8309593B2 (en) | 2008-10-03 | 2012-11-13 | Genzyme Corporation | 2-acylaminopropoanol-type glucosylceramide synthase inhibitors |
| MX2011011332A (es) | 2009-05-18 | 2011-11-18 | Orion Corp | Inhibidores de proteasas. |
| DE102009022794A1 (de) * | 2009-05-27 | 2010-12-02 | Philipps-Universität Marburg | Verwendung von Hemmstoffen der HAT und TMPRSS2 als Arzneimittel |
| RU2014123784A (ru) * | 2011-11-25 | 2015-12-27 | Ф. Хоффманн-Ля Рош Аг | Новые производные пирролидина в качестве ингибиторов катепсина |
| US9724351B2 (en) * | 2012-08-23 | 2017-08-08 | Alios Biopharma, Inc. | Compounds for the treatment of paramoxyvirus viral infections |
| CN105849102B (zh) * | 2013-10-29 | 2020-10-16 | 生物马林药物股份有限公司 | 作为葡萄糖基神经酰胺合酶抑制剂的n-(1-羟基-3(吡咯烷基)丙烷-2-基)吡咯烷-3-甲酰胺衍生物 |
| CN107153117B (zh) * | 2016-03-04 | 2019-02-19 | 中国人民解放军军事医学科学院生物工程研究所 | 一种用于判断靶向单克隆抗体治疗肿瘤疗效的预测分子 |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6235216A (ja) | 1985-08-09 | 1987-02-16 | Noritoshi Nakabachi | 不均質物質層の層厚非破壊測定方法および装置 |
| WO1993018007A1 (fr) | 1992-03-13 | 1993-09-16 | Tokyo Tanabe Company Limited | Nouveau derive de carbostyrile |
| US6150334A (en) * | 1994-11-21 | 2000-11-21 | Cortech, Inc. | Serine protease inhibitors-tripeptoid analogs |
| US5618792A (en) * | 1994-11-21 | 1997-04-08 | Cortech, Inc. | Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase |
| US5523308A (en) * | 1995-06-07 | 1996-06-04 | Costanzo; Michael J. | Peptidyl heterocycles useful in the treatment of thrombin related disorders |
| TW523513B (en) * | 1996-03-01 | 2003-03-11 | Akzo Nobel Nv | Serine protease inhibitors |
| EP1114822A3 (en) * | 1998-06-03 | 2002-11-13 | Cortech Inc. | Indoles and tetrahydroisoquinolines containing alpha-keto oxadiazoles as serine protease inhibitors |
| JP2004517028A (ja) * | 1998-06-03 | 2004-06-10 | コーテック インコーポレーテッド | セリンプロテアーゼ阻害剤としてのα−ケトオキサジアゾール類含有インドールおよびテトラヒドロイソキノリン |
| US6541669B1 (en) | 1998-06-08 | 2003-04-01 | Theravance, Inc. | β2-adrenergic receptor agonists |
| HUP0201295A3 (en) * | 1999-01-27 | 2002-10-28 | Ortho Mcneil Pharm Inc | Peptidyl heterocyclic ketones useful as tryptase inhibitors |
| JP2000256396A (ja) * | 1999-03-03 | 2000-09-19 | Dainippon Pharmaceut Co Ltd | 複素環式化合物およびその中間体ならびにエラスターゼ阻害剤 |
| GB9913083D0 (en) | 1999-06-04 | 1999-08-04 | Novartis Ag | Organic compounds |
| US6683115B2 (en) | 1999-06-02 | 2004-01-27 | Theravance, Inc. | β2-adrenergic receptor agonists |
| OA11558A (en) | 1999-12-08 | 2004-06-03 | Advanced Medicine Inc | Beta 2-adrenergic receptor agonists. |
| AU5629301A (en) | 2000-04-27 | 2001-11-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Novel, slow-acting betamimetics, a method for their production and their use as medicaments |
| GB0015876D0 (en) | 2000-06-28 | 2000-08-23 | Novartis Ag | Organic compounds |
| EP2067784A3 (en) | 2000-08-05 | 2012-08-22 | Glaxo Group Limited | 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivatives as anti-inflammatory agents |
| GB0103630D0 (en) | 2001-02-14 | 2001-03-28 | Glaxo Group Ltd | Chemical compounds |
| JP2004526720A (ja) | 2001-03-08 | 2004-09-02 | グラクソ グループ リミテッド | βアドレナリン受容体のアゴニスト |
| WO2002076933A1 (en) | 2001-03-22 | 2002-10-03 | Glaxo Group Limited | Formailide derivatives as beta2-adrenoreceptor agonists |
| WO2002088167A1 (en) | 2001-04-30 | 2002-11-07 | Glaxo Group Limited | Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha |
| ATE399174T1 (de) | 2001-06-12 | 2008-07-15 | Glaxo Group Ltd | Neue anti inflammatorische 17.alpha.- heterozyklische ester von 17.beta.-carbothioat androstan derivativen |
| ATE417606T1 (de) | 2001-09-14 | 2009-01-15 | Glaxo Group Ltd | Phenethanolamin-derivate zur behandlung von erkrankungen der atemwege |
| TWI249515B (en) | 2001-11-13 | 2006-02-21 | Theravance Inc | Aryl aniline beta2 adrenergic receptor agonists |
| US6653323B2 (en) | 2001-11-13 | 2003-11-25 | Theravance, Inc. | Aryl aniline β2 adrenergic receptor agonists |
| GB0204719D0 (en) | 2002-02-28 | 2002-04-17 | Glaxo Group Ltd | Medicinal compounds |
| ATE381535T1 (de) | 2002-04-25 | 2008-01-15 | Glaxo Group Ltd | Phenethanolaminderivate |
| EP1507754A1 (en) | 2002-05-28 | 2005-02-23 | Theravance, Inc. | Alkoxy aryl beta-2 adrenergic receptor agonists |
| GB0217225D0 (en) | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicinal compounds |
| PE20050130A1 (es) | 2002-08-09 | 2005-03-29 | Novartis Ag | Compuestos organicos |
| GB0220730D0 (en) | 2002-09-06 | 2002-10-16 | Glaxo Group Ltd | Medicinal compounds |
| DE10246374A1 (de) | 2002-10-04 | 2004-04-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Betamimetika mit verlängerter Wirkungsdauer, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
| EP1440966A1 (en) | 2003-01-10 | 2004-07-28 | Pfizer Limited | Indole derivatives useful for the treatment of diseases |
| ES2302938T3 (es) | 2002-10-11 | 2008-08-01 | Pfizer Inc. | Derivados de indol como agonistas beta-2. |
| RU2419625C2 (ru) * | 2006-05-23 | 2011-05-27 | Айрм Ллк | Соединения и композиции в качестве ингибиторов протеазы, активирующей каналы |
| US7951823B2 (en) * | 2006-05-23 | 2011-05-31 | Irm Llc | Compounds and compositions as channel activating protease inhibitors |
-
2008
- 2008-01-04 EP EP08713564A patent/EP2117541A1/en not_active Withdrawn
- 2008-01-04 US US12/525,991 patent/US20100239551A1/en not_active Abandoned
- 2008-01-04 CN CN200880004423A patent/CN101646437A/zh active Pending
- 2008-01-04 EA EA200901082A patent/EA200901082A1/ru unknown
- 2008-01-04 WO PCT/US2008/050289 patent/WO2008097673A1/en not_active Ceased
- 2008-01-04 MX MX2009008493A patent/MX2009008493A/es active IP Right Grant
- 2008-01-04 BR BRPI0806970-0A2A patent/BRPI0806970A2/pt not_active IP Right Cessation
- 2008-01-04 CA CA002677485A patent/CA2677485A1/en not_active Abandoned
- 2008-01-04 AU AU2008214214A patent/AU2008214214B2/en not_active Ceased
- 2008-01-04 JP JP2009549148A patent/JP2010518097A/ja active Pending
- 2008-02-05 TW TW097104668A patent/TW200845982A/zh unknown
- 2008-02-08 AR ARP080100549A patent/AR065266A1/es unknown
- 2008-02-08 PE PE2008000284A patent/PE20081753A1/es not_active Application Discontinuation
- 2008-02-08 CL CL200800408A patent/CL2008000408A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2117541A1 (en) | 2009-11-18 |
| WO2008097673A1 (en) | 2008-08-14 |
| CA2677485A1 (en) | 2008-08-14 |
| EA200901082A1 (ru) | 2010-02-26 |
| US20100239551A1 (en) | 2010-09-23 |
| PE20081753A1 (es) | 2009-01-22 |
| MX2009008493A (es) | 2009-08-20 |
| AU2008214214B2 (en) | 2011-09-15 |
| AU2008214214A1 (en) | 2008-08-14 |
| CN101646437A (zh) | 2010-02-10 |
| AR065266A1 (es) | 2009-05-27 |
| CL2008000408A1 (es) | 2008-08-29 |
| TW200845982A (en) | 2008-12-01 |
| JP2010518097A (ja) | 2010-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0807483A2 (pt) | Compostos e composições como inibidores de protease de ativação de canal | |
| BRPI0816786A2 (pt) | Canal | |
| BRPI0922084A2 (pt) | Composições e métodos compreendendo variantes de serina protease | |
| BRPI0807547A2 (pt) | Inibidores de aspartil protease hetercíclicos | |
| LTPA2017010I1 (lt) | Proteazomos inhibitoriai | |
| ATE461177T1 (de) | Ionenkanal-hemmer | |
| PL2104535T3 (pl) | Związki i kompozycje jako inhibitory proteazy aktywujące kanały | |
| BRPI0719499A2 (pt) | Composições de poliolefina | |
| EP2046887A4 (en) | Light-Crosslinkable Polyolefin Compositions | |
| BRPI0808192A2 (pt) | composto e composições como moduladores de atividades de gpr119 | |
| BRPI0914652A2 (pt) | compostos e composições como inibidores de quinase | |
| BRPI0912668A2 (pt) | composto e composições como inibidores de quinase | |
| ME01423B (me) | Fungicidni sastavi | |
| HUE059171T2 (hu) | Kompozíciók | |
| EP2218175A4 (en) | Switching amplifiers | |
| LT3575288T (lt) | Chinazolinai kaip kalio jonų kanalų inhibitoriai | |
| EP2381760A4 (en) | CORN PROTEIN COMPOSITION | |
| BRPI0816494A2 (pt) | Composição vedante melhorada | |
| ATE528048T1 (de) | Schweisshemmende/desodorierende zusammensetzung | |
| PL2019837T3 (pl) | Związki i kompozycje jako inhibitory proteazy aktywującej kanały | |
| BRPI0910979A2 (pt) | compostos e composições como inibidores de quinase | |
| BRPI0914545A2 (pt) | compostos e composições como inibidores de quinase | |
| DK2214640T3 (da) | Intranasale sammensætninger | |
| BRPI0910691A2 (pt) | compostos e composições como inibidores de itpkb | |
| BRPI0718141A2 (pt) | Composições de frangrâncias |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2277 DE 26/08/2014. |